I’ve come to see the full weight of how cancer therapies heal—and harm—all at once.
It is a paradox that sits heavily in the hospital room, between the machines, the monitors, and the quiet hum of human determination.
The moment you witness it firsthand, you understand that the tools designed to save life can sometimes make living unbearable.
Sasha lies there, her small body curled beneath crisp hospital sheets.
The pain has spread to both sides of her jaw, a relentless ache that refuses to yield.
It is the kind of pain that strips everything away until all that remains is raw will and determination.
Every movement becomes a choice, every word a triumph, every swallow a silent victory.
Because the pain has moved to her other jaw as well, her care team suspects that her Cabo medicine may be contributing.
Cabo, a potent anti-cancer therapy, works by cutting off the blood supply tumors need to grow.
It is effective, powerful, and has kept Sasha’s head scans clear of visible disease.
Those scans are celebrated fiercely, a beacon of hope in the uncertain world of oncology.
But like many medicines, Cabo is not selective.
It does exactly what it was designed to do: it starves.
And when it starves, it does not discriminate between tumor and healthy tissue.
Nerves, deprived of oxygen and nourishment, do not go quiet—they scream.
Watching Sasha’s face tighten, her small hands clutching the sheets, her eyes wet with unspoken pain, it becomes clear just how intricate the balance of healing and harm can be.
The decision to pause Cabo is not taken lightly.
It is a strategic, deliberate move, a pivot informed by careful listening to Sasha’s body and her biology.
Instead, the team will move forward with high-dose Ifosfamide chemotherapy.





















